Date de publication: 17 décembre 2007
Promoteur – Intermédiaire Financier
Sanofi-Aventis
Lieu
Description
The project concerns the design, construction or modernisation, and the equipment of several buildings providing facilities for pharmacological research, product development facilities and office space in Europe.
Objectifs
The project aims at regrouping and reorganizing the promoter’s R&D activities in order to optimize the use of premises and equipments and facilitate the synergies between different therapeutic areas. It concerns the design, construction or modernisation, and the equipment of several buildings providing facilities for pharmacological research and office space in Europe. The facilities will be located in France, Germany, United Kingdom, Spain and Italy, mostly in the promoter’s existing R&D sites.
Secteur(s)
Montant BEI envisagé (montant approximatif)
EUR 350 million.
Coût total (montant approximatif)
EUR 999 million.
Aspects environnementaux
The sub-projects fall under Annex II of the directive EU/97/11 amended by Directive 2003/35/EC on Environmental Impact Assessment (EIA). The determination made by the competent authorities for requesting (or not) an EIA on the basis of Annex III of the Directive and actual/possible significant impacts on protected flora and fauna (Habitats’ and Birds’ Directives) has been verified during project appraisal.
Passation des marchés
The promoter is a private company not operating in the Utilities sector, and is thus not covered by EU Directives on procurement. Procedures followed have been verified during appraisal.
Statut
Signé - 13/12/2007
Clause de non-responsabilité
Avant d’être approuvés par le Conseil d’administration et avant la signature des prêts correspondants, les projets font l’objet d’une instruction et de négociations. Par conséquent, les informations et données fournies sur cette page sont indicatives.
Elles sont fournies à des fins de transparence uniquement et ne peuvent être considérées comme représentant la politique officielle de la BEI (voir également les notes explicatives).